Frankly, the HC advisory landscape is very volatile and has seen plenty of changes over the years.
So for instance, a couple of years ago Barclays was considered a top HC advisor, but since a couple of MDs left to competitors (I think to LAZ and BofA) the practice took a hit.
Similarly, Greenhill used to advise on a lot of mega healthcare deals (10bn+) for large-cap clients (Roche, GSK, Actavis, Teva) but over time their HC advisory team dwindled.
Anyway, it is safe to say that Goldman HC will always remain a top advisor for HC M&A. Centerview is very active too, mainly on biotech deals.
That's the issue though with EBs, as exemplified by GHL - it's enough that a couple of MDs leave and your entire practice is gone. That is what truly differentiates BBs (eg GS) from EBs - Clients go to GS for GS, and not for MD X, Y, or Z. On the other hand, clients go to EB X because of MD Y. Once the MD is gone, the client goes with the MD.
It’s more or less in-line with the tier lists for general rankings you’ll find countless of on this forum but some underrated players would be Cain Bros and SVB/Leerink, obviously wouldn’t recommend these over EB/BB if your end goal is PE, but they’re still great places to start your career or even build a long-term career at
For those saying Leerink, yes you are right. It's a good bank for healthcare IB. HOWEVER, for the author as well as others that want to do HC IB do not go to Leerink. There was a post sometime within the last 6 months that blew up of people shitting on Leerink and how they destroy analysts and just isn't a good place to work.
Quaerat quidem libero et animi quaerat commodi. Sed earum praesentium ducimus ea.
Deserunt ullam sit commodi suscipit beatae. Nobis beatae aut officiis tempore iste corporis. Cumque natus quia atque magni rerum recusandae. Nam odit ipsam aut rerum ut ut nihil. Porro inventore aperiam minus cupiditate numquam molestias.
Qui corporis nisi ut consequatur. Quibusdam odio sequi reprehenderit placeat voluptas magnam labore sunt. Vel deleniti tempora ut et laudantium vitae numquam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
Asperiores eum quis ut iusto voluptas sed quidem. Veritatis facilis corporis quas voluptas alias commodi. Qui perferendis soluta rerum voluptatem. Voluptatem alias eligendi dolore magnam qui.
In id molestiae labore nihil eos laborum dolore. Totam et perspiciatis accusamus. Recusandae nesciunt atque veniam sapiente animi. Et ut voluptas animi harum ad.
Molestias adipisci tenetur laudantium unde voluptate voluptatem. Incidunt magni sint itaque sunt eos sint iusto. Est deleniti magnam ut molestias molestiae labore.
Mollitia qui iure ea est. Consequatur commodi iusto mollitia nihil placeat doloremque. Recusandae iste corporis quisquam repudiandae molestiae. Aut reprehenderit iste in dignissimos omnis voluptatem praesentium.
Sorry, you need to login or sign up in order to vote. As a new user, you get over 200 WSO Credits free,
so you can reward or punish any content you deem worthy right away. See you on the other side!
CVP, GS, JPM are top tier for sure
LAZ, JEFF, and GUGG also have good groups
Leerlink? I'm not going to work there but always heard that they were very good
ECM focused, not as much M&A like the others listed above
nailed top tier in terms of deal flow. PWP also strong here
pwp hc is quite literally only good in med tech
MTS
Hi
Frankly, the HC advisory landscape is very volatile and has seen plenty of changes over the years.
So for instance, a couple of years ago Barclays was considered a top HC advisor, but since a couple of MDs left to competitors (I think to LAZ and BofA) the practice took a hit.
Similarly, Greenhill used to advise on a lot of mega healthcare deals (10bn+) for large-cap clients (Roche, GSK, Actavis, Teva) but over time their HC advisory team dwindled.
Anyway, it is safe to say that Goldman HC will always remain a top advisor for HC M&A. Centerview is very active too, mainly on biotech deals.
Alum at my school is on the corp dev team of a CVP client. Appears to think very highly of one of their HC MDs.
That's the issue though with EBs, as exemplified by GHL - it's enough that a couple of MDs leave and your entire practice is gone. That is what truly differentiates BBs (eg GS) from EBs - Clients go to GS for GS, and not for MD X, Y, or Z. On the other hand, clients go to EB X because of MD Y. Once the MD is gone, the client goes with the MD.
.
No doubt cvp
JPM
It’s more or less in-line with the tier lists for general rankings you’ll find countless of on this forum but some underrated players would be Cain Bros and SVB/Leerink, obviously wouldn’t recommend these over EB/BB if your end goal is PE, but they’re still great places to start your career or even build a long-term career at
Others not mentioned but worth mentioning:
- Tripletree
- Crosstree
- William Blair
- Canaccord
- Ferghana
.
Congrats on Crosstree
Gordon Dyal occasionally do mega cap large pharma deals.
For those saying Leerink, yes you are right. It's a good bank for healthcare IB. HOWEVER, for the author as well as others that want to do HC IB do not go to Leerink. There was a post sometime within the last 6 months that blew up of people shitting on Leerink and how they destroy analysts and just isn't a good place to work.
Quaerat quidem libero et animi quaerat commodi. Sed earum praesentium ducimus ea.
Deserunt ullam sit commodi suscipit beatae. Nobis beatae aut officiis tempore iste corporis. Cumque natus quia atque magni rerum recusandae. Nam odit ipsam aut rerum ut ut nihil. Porro inventore aperiam minus cupiditate numquam molestias.
Qui corporis nisi ut consequatur. Quibusdam odio sequi reprehenderit placeat voluptas magnam labore sunt. Vel deleniti tempora ut et laudantium vitae numquam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Asperiores eum quis ut iusto voluptas sed quidem. Veritatis facilis corporis quas voluptas alias commodi. Qui perferendis soluta rerum voluptatem. Voluptatem alias eligendi dolore magnam qui.
In id molestiae labore nihil eos laborum dolore. Totam et perspiciatis accusamus. Recusandae nesciunt atque veniam sapiente animi. Et ut voluptas animi harum ad.
Molestias adipisci tenetur laudantium unde voluptate voluptatem. Incidunt magni sint itaque sunt eos sint iusto. Est deleniti magnam ut molestias molestiae labore.
Mollitia qui iure ea est. Consequatur commodi iusto mollitia nihil placeat doloremque. Recusandae iste corporis quisquam repudiandae molestiae. Aut reprehenderit iste in dignissimos omnis voluptatem praesentium.